FLUOGUIDE A/S DK -1 Market Cap ($50.27 Million)
Market Cap & Net Worth: FLUOGUIDE A/S DK -1 (96X)
FLUOGUIDE A/S DK -1 market cap. FLUOGUIDE A/S DK -1 (F:96X) has a market capitalization of $50.27 Million (€43.00 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #21707 globally and #1931 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying FLUOGUIDE A/S DK -1's stock price €2.63 by its total outstanding shares 16349313 (16.35 Million). Also see cash flow conversion of FLUOGUIDE A/S DK -1 for how efficiently the company converts equity into cash flow.
FLUOGUIDE A/S DK -1 Market Cap History (2021–2026)
FLUOGUIDE A/S DK -1 market cap history from 2021 to 2026. Data shows change from $159.03 Million to $50.27 Million (-25.49% CAGR). Check FLUOGUIDE A/S DK -1 share price for real-time trading data and today's change.
FLUOGUIDE A/S DK -1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how FLUOGUIDE A/S DK -1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore FLUOGUIDE A/S DK -1 annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 96X by Market Capitalization
Companies near FLUOGUIDE A/S DK -1 in the global market cap rankings as of November 3, 2026. Also see 96X asset base for a full breakdown of the balance sheet.
Key companies related to FLUOGUIDE A/S DK -1 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of FLUOGUIDE A/S DK -1 (2021–2026)
Market capitalization of FLUOGUIDE A/S DK -1 from 2021 to today. Between 2021 and today, FLUOGUIDE A/S DK -1's market cap moved from $159.03 Million to $ 50.27 Million, with a yearly change of -25.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €50.27 Million | -14.61% |
| 2025 | €58.87 Million | -1.60% |
| 2024 | €59.83 Million | -37.40% |
| 2023 | €95.57 Million | +52.91% |
| 2022 | €62.50 Million | -60.70% |
| 2021 | €159.03 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of FLUOGUIDE A/S DK -1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.27 Million USD |
| MoneyControl | $50.27 Million USD |
| MarketWatch | $50.27 Million USD |
| marketcap.company | $50.27 Million USD |
| Reuters | $50.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About FLUOGUIDE A/S DK -1
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more